Detalhe da pesquisa
1.
Interleukin 33 is a guardian of barriers and a local alarmin.
Nat Immunol;
17(2): 122-31, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26784265
2.
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection.
Mol Ther;
30(5): 1885-1896, 2022 05 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34687845
3.
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
Mol Ther;
29(6): 1984-2000, 2021 06 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33578036
4.
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
Int J Mol Sci;
22(5)2021 Feb 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33668756
5.
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.
Pharmaceuticals (Basel);
16(5)2023 May 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37242495
6.
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.
Nat Commun;
14(1): 3035, 2023 05 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37236967
7.
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Front Immunol;
13: 1050250, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36713447
8.
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization.
Membranes (Basel);
10(9)2020 Aug 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32872641
9.
Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy.
Nat Commun;
10(1): 3236, 2019 07 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31324774
10.
Targeting polysialic acid-abundant cancers using oncolytic adenoviruses with fibers fused to active bacteriophage borne endosialidase.
Biomaterials;
158: 86-94, 2018 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29304405
11.
Brief Communication; A Heterologous Oncolytic Bacteria-Virus Prime-Boost Approach for Anticancer Vaccination in Mice.
J Immunother;
41(3): 125-129, 2018 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29293165
12.
PolySia-Specific Retargeting of Oncolytic Viruses Triggers Tumor-Specific Immune Responses and Facilitates Therapy of Disseminated Lung Cancer.
Cancer Immunol Res;
3(7): 751-63, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25701327